je.st
news
Tag: biosimilar
Amgen, Allergan Biosimilar Avastin Hits In Trial
2015-09-24 17:07:51| Biotech - Topix.net
Amgen and Allergan, which started their collaboration back in 2011 when Allergan was a generic drug maker called Watson Pharmaceuticals, released few details but said the drug ABP 215 had shown clinical equivalence to Avastin as measured by tumor shrinkage, duration of response and progression-free survival. Launched in 2004, Avastin is drawing $7 billion for Roche as a treatment for a variety of different cancers, about 20% to 25% of it from lung cancer.
Tags: trial
hits
amgen
allergan
First 'biosimilar' of a biologic drug reaches US, finally
2015-09-11 00:00:59| Biotech - Topix.net
Years after discounted versions of some of the most expensive drugs ever went on sale in other countries, they're finally coming to the world's biggest medicine market. Last week brought the first U.S. launch in a new category called "biosimilars."
First 'biosimilar' of a biologic drug reaches US, finally
2015-09-11 00:00:58| Biotech - Topix.net
" Years after discounted versions of some of the most expensive drugs ever went on sale in other countries, they're finally coming to the world's biggest medicine market. Last week brought the first U.S. launch in a new category called "biosimilars."
Merck and Samsung Bioepis Announce Approval of BRENZYS (Etanercept), a Biosimilar of Enbrel, in Korea
2015-09-08 14:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. & SEOUL, South Korea First Product from Global Partnership to Deliver High-Quality Biosimilars to Help Meet Needs of Patients and Healthcare Systems Worldwide KENILWORTH, N.J. & SEOUL, South Korea--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced the approval of BRENZYS (etanercept), a biosimilar of the immunology medicine Enbrel, by the Ministry of Food and Drug Safety (MFDS) in Korea. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Robert Consalvo, 908-236-1127orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879orSamsung BioepisMedia:Jamyung Cha, (82) 32-455-6137orInvestors:Sungjoon Park, (82) 32-455-6120 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
korea
samsung
approval
[Newsmaker] Samsung's first biosimilar drug gains domestic approval
2015-09-08 11:51:41| Biotech - Topix.net
Samsung Group, South Korea's leading conglomerate, has taken a significant step toward driving forward its newly-established biopharmaceuticals business, an emerging sector expected to become one of the company's future growth engines. Samsung Bioepis, the conglomerate's biotechnology research and development unit, said Monday that it had gained approval from the Ministry of Food and Drug Safety to begin selling Brenzys, its biosimilar copy of Pfizer's rheumatoid arthritis treatment Enbrel, in South Korea.
Tags: drug
approval
domestic
gains